Iovance Biotherapeutics Inc IOVA
NASDAQ · United States · Health Technology
$14.23-0.59 (-3.98%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.11 | -0.13 | +17.6% | $99.31M | +13.1% | +46.1%$4.34→$6.34 |
| Q1 2026 | 2026-05-07 | -0.19 | -0.15 | -26.7% | — | — | -11.5%$4.09→$3.62 |
| Q4 2025 | 2026-02-24 | -0.18 | -0.18 | 0.0% | — | — | +32.5%$2.89→$3.83 |
| Q3 2025 | 2025-11-06 | -0.25 | -0.26 | +3.8% | — | — | +27.1%$1.81→$2.30 |
| Q2 2025 | 2025-08-07 | -0.33 | -0.28 | -17.9% | — | — | — |
| Q1 2025 | 2025-05-08 | -0.36 | -0.24 | -50.0% | — | — | — |
| Q4 2024 | 2025-02-26 | -0.26 | -0.27 | +3.7% | — | — | — |
| Q3 2024 | 2024-11-07 | -0.28 | -0.30 | +6.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.